search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
174 new news items in the last 24 hours
  1. Home
  2. International

King's College London has developed an experimental drug that improves the response of chemotherapy-resistant tumors by targeting a tumor defense protein.

Ana Maria Eftene
whatsapp
facebook
linkedin
x
copy-link copy-link
15 August 2025, 09:21
main event image
International
Foto: Pexels.com
google-preference

Always see our news on Google

The drug KCL-HO-1i developed by researchers at King's College London has the potential to transform treatments for chemotherapy-resistant cancers. It works by neutralizing the protein heme oxygenase-1 (HO-1), which helps tumors protect themselves from chemotherapy and immune system attacks. Preclinical tests have shown that the drug can make tumors more responsive to chemotherapy, even in previously resistant cases. Designed for oral administration, KCL-HO-1i could begin human clinical trials in two years, with the potential to expand its applications in oncology.

Sources

sursa imagine
Ziare.com
Speranță pentru bolnavii de cancer: Un nou medicament sporește eficacitatea chimioterapiei chiar și în cazul tumorilor rezistente
sursa imagine
Stiripesurse
A apărut pastila care dezarmează cancerul! Descoperirea care ar putea rescrie regulile chimioterapiei: Chiar și cele mai rezistente tumori răspund la tratament

Latest News

23:51

Traian Băsescu criticizes Dacian Cioloș’s candidacy for the leadership of the Francophonie: “An immorality”

23:26

Jared Kushner Announces Progress in Negotiations to End the War in Ukraine

22:58

The Trump administration tightens rules on exporting U.S. chips to third countries to limit China’s access to AI technology

22:48

Zelenskyy asks European allies for missiles for Ukraine, following talks with US envoys about negotiations with Russia

22:38

Transgaz Director: The Mintia Power Plant Begins Commercial Production with the First Turbine, While the Second Enters Testing

See more news

NEWS ON THE SAME TOPICS

event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
Current Affairs
Cluj Oncology Institute represents Romania in the second stage of the European ECHoS project, dedicated to combating cancer
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
medically cancer chemotherapy

Editor’s Recommendations

main event image
Politics
4 hours ago

Luca Niculescu: “In the third quarter, Romania recorded the second-highest economic growth in the European Union”

Sources
imagine sursa
imagine sursa
imagine sursa
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol